James R. Hollingshead's Insider Trades & SAST Disclosures
James R. Hollingshead's most recent trade in Insulet Corporation was a trade of 1,160 Common Stock done at an average price of $272.3 . Disclosure was reported to the exchange on Feb. 28, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern James R. Hollingshead.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Insulet Corporation | James R. Hollingshead | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 272.27 per share. | 28 Feb 2025 | 1,160 | 64,834 (0%) | 0% | 272.3 | 315,833 | Common Stock |
| Insulet Corporation | James R. Hollingshead | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 267.09 per share. | 27 Feb 2025 | 2,074 | 65,994 (0%) | 0% | 267.1 | 553,945 | Common Stock |
| Insulet Corporation | James R. Hollingshead | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 19,458 | 19,458 | - | - | Employee Stock Option (Right to Buy) | |
| Insulet Corporation | James R. Hollingshead | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 7,687 | 68,068 (0%) | 0% | 0 | Common Stock | |
| Insulet Corporation | James R. Hollingshead | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2025 | 36,671 | 78,400 (0%) | 0% | 0 | Common Stock | |
| Insulet Corporation | James R. Hollingshead | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 280.56 per share. | 17 Feb 2025 | 18,019 | 60,381 (0%) | 0% | 280.6 | 5,055,411 | Common Stock |
| Insulet Corporation | James R. Hollingshead | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 177.19 per share. | 31 May 2024 | 3,973 | 41,599 (0%) | 0% | 177.2 | 703,976 | Common Stock |
| Insulet Corporation | R. Hollingshead James | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 29,475 | 29,475 | - | - | Stock Option (Right to Buy) | |
| Insulet Corporation | Hollingshead James R. | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 12,303 | 46,480 (0%) | 0% | 0 | Common Stock | |
| Insulet Corporation | R. James Hollingshead | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 163.60 per share. | 27 Feb 2024 | 908 | 45,572 (0%) | 0% | 163.6 | 148,549 | Common Stock |
| Insulet Corporation | James R. Hollingshead | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 181.41 per share. | 28 Aug 2023 | 5,550 | 34,177 (0%) | 0% | 181.4 | 1,006,826 | Common Stock |
| Insulet Corporation | James R. Hollingshead | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 272.48 per share. | 01 Jun 2023 | 3,898 | 28,627 (0%) | 0% | 272.5 | 1,062,127 | Common Stock |
| Insulet Corporation | James R. Hollingshead | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 16,475 | 16,475 | - | - | Employee Stock Option (Right to Buy) | |
| Insulet Corporation | James R. Hollingshead | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 6,875 | 32,444 (0%) | 0% | 0 | Common Stock | |
| Insulet Corporation | James R. Hollingshead | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 21,699 | 25,569 (0%) | 0% | 0 | Common Stock | |
| Resmed Inc. | James R. Hollingshead | President, Sleep Business | Sale of securities on an exchange or to another person at price $ 256.84 per share. | 01 Dec 2021 | 2,400 | 76,721 (0%) | 0% | 256.8 | 616,416 | ResMed Common Stock |
| Resmed Inc. | James R. Hollingshead | President, Sleep Business | Grant, award, or other acquisition of securities at price $ 254.81 per share. | 16 Nov 2021 | 20,360 | 89,472 (0%) | 0% | 254.8 | 5,187,932 | ResMed Common Stock |
| Resmed Inc. | James R. Hollingshead | President, Sleep Business | Payment of exercise price or tax liability using portion of securities received from the company at price $ 254.81 per share. | 16 Nov 2021 | 12,060 | 77,412 (0%) | 0% | 254.8 | 3,073,009 | ResMed Common Stock |
| Resmed Inc. | James R. Hollingshead | President, Sleep Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Nov 2021 | 1,393 | 78,805 (0%) | 0% | 0 | ResMed Common Stock | |
| Resmed Inc. | James R. Hollingshead | President, Sleep Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Nov 2021 | 316 | 79,121 (0%) | 0% | 0 | ResMed Common Stock | |
| Resmed Inc. | James R. Hollingshead | President, Sleep Business | Payment of exercise price or tax liability using portion of securities received from the company at price $ 259.47 per share. | 11 Nov 2021 | 4,100 | 69,112 (0%) | 0% | 259.5 | 1,063,827 | ResMed Common Stock |
| Resmed Inc. | James R. Hollingshead | President, Sleep Business | Sale of securities on an exchange or to another person at price $ 264.35 per share. | 01 Nov 2021 | 2,400 | 73,177 (0%) | 0% | 264.3 | 634,430 | ResMed Common Stock |
| Resmed Inc. | James R. Hollingshead | President, Sleep Business | Sale of securities on an exchange or to another person at price $ 261.33 per share. | 01 Oct 2021 | 2,400 | 74,479 (0%) | 0% | 261.3 | 627,183 | ResMed Common Stock |
| Resmed Inc. | James R. Hollingshead | President, Sleep Business | Sale of securities on an exchange or to another person at price $ 287.30 per share. | 01 Sep 2021 | 2,400 | 76,879 (0%) | 0% | 287.3 | 689,527 | ResMed Common Stock |
| Resmed Inc. | James R. Hollingshead | President, Sleep Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2021 | 5,741 | 79,279 (0%) | 0% | 0 | ResMed Common Stock | |
| Resmed Inc. | James R. Hollingshead | President, Sleep Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2021 | 1,332 | 80,611 (0%) | 0% | 0 | ResMed Common Stock | |
| Resmed Inc. | James R. Hollingshead | President, Sleep Business | Payment of exercise price or tax liability using portion of securities received from the company at price $ 246.52 per share. | 19 Aug 2021 | 234 | 75,577 (0%) | 0% | 246.5 | 57,686 | ResMed Common Stock |
| Resmed Inc. | James R. Hollingshead | President, Sleep Business | Sale of securities on an exchange or to another person at price $ 268.94 per share. | 02 Aug 2021 | 2,400 | 73,538 (0%) | 0% | 268.9 | 645,464 | ResMed Common Stock |
| Resmed Inc. | James R. Hollingshead | President, Sleep Business | Sale of securities on an exchange or to another person at price $ 247.30 per share. | 01 Jul 2021 | 2,400 | 75,938 (0%) | 0% | 247.3 | 593,513 | ResMed Common Stock |
| Resmed Inc. | James R. Hollingshead | President, Sleep Business | Sale of securities on an exchange or to another person at price $ 206.03 per share. | 01 Jun 2021 | 2,400 | 78,338 (0%) | 0% | 206.0 | 494,475 | ResMed Common Stock |
| Insulet Corporation | James R. Hollingshead | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2021 | 808 | 3,870 (0%) | 0% | 0 | Common Stock | |
| Resmed Inc. | James R. Hollingshead | President, Sleep Business | Sale of securities on an exchange or to another person at price $ 202.01 per share. | 21 May 2021 | 2,400 | 80,738 (0%) | 0% | 202.0 | 484,824 | ResMed Common Stock |
| Resmed Inc. | James R. Hollingshead | President, Sleep Business | Sale of securities on an exchange or to another person at price $ 200.00 per share. | 12 Apr 2021 | 4,800 | 83,046 (0%) | 0% | 200 | 960,000 | ResMed Common Stock |
| Resmed Inc. | James R. Hollingshead | President, Sleep Business | Sale of securities on an exchange or to another person at price $ 200.18 per share. | 01 Feb 2021 | 2,400 | 87,846 (0%) | 0% | 200.2 | 480,437 | ResMed Common Stock |
| Resmed Inc. | James R. Hollingshead | President, Sleep Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2021 | 1,913 | 90,246 (0%) | 0% | 0 | ResMed Common Stock | |
| Resmed Inc. | James R. Hollingshead | President, Sleep Business | Sale of securities on an exchange or to another person at price $ 211.09 per share. | 04 Jan 2021 | 2,400 | 88,333 (0%) | 0% | 211.1 | 506,614 | ResMed Common Stock |
| Resmed Inc. | James R. Hollingshead | President, Sleep Business | Sale of securities on an exchange or to another person at price $ 210.97 per share. | 01 Dec 2020 | 2,400 | 90,733 (0%) | 0% | 211.0 | 506,330 | ResMed Common Stock |
| Resmed Inc. | James R. Hollingshead | President, Sleep Business | Grant, award, or other acquisition of securities at price $ 214.74 per share. | 17 Nov 2020 | 26,246 | 108,680 (0%) | 0% | 214.7 | 5,636,066 | ResMed Common Stock |
| Resmed Inc. | James R. Hollingshead | President, Sleep Business | Payment of exercise price or tax liability using portion of securities received from the company at price $ 214.74 per share. | 17 Nov 2020 | 15,547 | 93,133 (0%) | 0% | 214.7 | 3,338,563 | ResMed Common Stock |
| Resmed Inc. | James R. Hollingshead | President, Sleep Business | Payment of exercise price or tax liability using portion of securities received from the company at price $ 212.11 per share. | 11 Nov 2020 | 2,135 | 85,524 (0%) | 0% | 212.1 | 452,855 | ResMed Common Stock |
| Resmed Inc. | James R. Hollingshead | President, Sleep Business | Payment of exercise price or tax liability using portion of securities received from the company at price $ 212.11 per share. | 11 Nov 2020 | 1,804 | 83,720 (0%) | 0% | 212.1 | 382,646 | ResMed Common Stock |
| Resmed Inc. | James R. Hollingshead | President, Sleep Business | Payment of exercise price or tax liability using portion of securities received from the company at price $ 212.11 per share. | 11 Nov 2020 | 1,286 | 82,434 (0%) | 0% | 212.1 | 272,773 | ResMed Common Stock |
| Resmed Inc. | James R. Hollingshead | President, Sleep Business | Sale of securities on an exchange or to another person at price $ 195.00 per share. | 02 Nov 2020 | 2,400 | 87,602 (0%) | 0% | 195.0 | 467,996 | ResMed Common Stock |
| Resmed Inc. | James R. Hollingshead | President, Sleep Business | Sale of securities on an exchange or to another person at price $ 170.43 per share. | 01 Oct 2020 | 2,400 | 90,002 (0%) | 0% | 170.4 | 409,023 | ResMed Common Stock |
| Resmed Inc. | James R. Hollingshead | President, Sleep Business | Sale of securities on an exchange or to another person at price $ 202.02 per share. | 01 Sep 2020 | 2,400 | 92,402 (0%) | 0% | 202.0 | 484,854 | ResMed Common Stock |
| Resmed Inc. | James R. Hollingshead | President, Sleep Business | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2020 | 7,328 | 94,802 (0%) | 0% | 0 | ResMed Common Stock | |
| Resmed Inc. | James R. Hollingshead | President, Sleep Business | Sale of securities on an exchange or to another person at price $ 202.02 per share. | 03 Aug 2020 | 2,400 | 87,474 (0%) | 0% | 202.0 | 484,854 | ResMed Common Stock |
| Resmed Inc. | James R. Hollingshead | President, Sleep Business | Sale of securities on an exchange or to another person at price $ 189.63 per share. | 01 Jul 2020 | 2,400 | 89,874 (0%) | 0% | 189.6 | 455,112 | ResMed Common Stock |
| Resmed Inc. | James R. Hollingshead | President, Sleep Business | Sale of securities on an exchange or to another person at price $ 160.13 per share. | 01 Jun 2020 | 1,200 | 92,274 (0%) | 0% | 160.1 | 192,156 | ResMed Common Stock |
| Insulet Corporation | James R. Hollingshead | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2020 | 1,029 | 3,062 (0%) | 0% | 0 | Common Stock | |
| Resmed Inc. | James R. Hollingshead | President, Sleep Business | Sale of securities on an exchange or to another person at price $ 164.00 per share. | 01 May 2020 | 1,200 | 93,365 (0%) | 0% | 164 | 196,800 | ResMed Common Stock |
| Resmed Inc. | James R. Hollingshead | President, Sleep Business | Sale of securities on an exchange or to another person at price $ 150.00 per share. | 02 Apr 2020 | 1,200 | 94,565 (0%) | 0% | 150 | 180,000 | ResMed Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges